Sector Chart Hemogenyx Pharmaceuticals Plc
Stocks
SILF
GB00BQVXM815
Biotechnology & Medical Research
|
Market Closed -
London S.E.
11:35:22 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 570.00 GBX | -2.56% |
|
+0.71% | -0.35% |
| 10-19 | Cora Gold shareholder Eagle Eye restructures holding | AN |
| 10-19 | Hemogenyx Pharmaceuticals Partners with Nitto Denko to Explore CAR mRNA's Lipid Nanoparticle Delivery | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 53.59M | - | - | - | - | - |
| 69.4B | |||||
| 57.24B | |||||
| 57.62B | |||||
| 43.65B | |||||
| 44.03B |
Select your edition
All financial news and data tailored to specific country editions
